Your browser doesn't support javascript.
loading
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery.
De Witt Hamer, Philip C; Ho, Vincent K Y; Zwinderman, Aeilko H; Ackermans, Linda; Ardon, Hilko; Boomstra, Sytske; Bouwknegt, Wim; van den Brink, Wimar A; Dirven, Clemens M; van der Gaag, Niels A; van der Veer, Olivier; Idema, Albert J S; Kloet, Alfred; Koopmans, Jan; Ter Laan, Mark; Verstegen, Marco J T; Wagemakers, Michiel; Robe, Pierre A J T.
Afiliação
  • De Witt Hamer PC; Department of Neurosurgery, Neurosurgical Center Amsterdam, Location VU Medical Center, Amsterdam, The Netherlands. p.dewitthamer@amsterdamumc.nl.
  • Ho VKY; Department of Neurosurgery, Amsterdam University Medical Centers, Location VU Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. p.dewitthamer@amsterdamumc.nl.
  • Zwinderman AH; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Ackermans L; Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands.
  • Ardon H; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Boomstra S; Department of Neurosurgery, St Elisabeth Hospital, Tilburg, The Netherlands.
  • Bouwknegt W; Department of Neurosurgery, Medical Spectrum Twente, Enschede, The Netherlands.
  • van den Brink WA; Department of Neurosurgery, Medical Center Slotervaart, Amsterdam, The Netherlands.
  • Dirven CM; Department of Neurosurgery, Isala, Zwolle, The Netherlands.
  • van der Gaag NA; Department of Neurosurgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van der Veer O; HAGA Teaching Hospital, The Hague, The Netherlands.
  • Idema AJS; Leiden University Medical Center, Leiden, The Netherlands.
  • Kloet A; Department of Neurosurgery, Medical Spectrum Twente, Enschede, The Netherlands.
  • Koopmans J; Department of Neurosurgery, Northwest Clinics, Alkmaar, The Netherlands.
  • Ter Laan M; Department of Neurosurgery, Medical Center Haaglanden, The Hague, The Netherlands.
  • Verstegen MJT; Department of Neurosurgery, Martini Hospital, Groningen, The Netherlands.
  • Wagemakers M; Department of Neurosurgery, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Robe PAJT; Leiden University Medical Center, Leiden, The Netherlands.
J Neurooncol ; 144(2): 313-323, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31236819
ABSTRACT

PURPOSE:

Standards for surgical decisions are unavailable, hence treatment decisions can be personalized, but also introduce variation in treatment and outcome. National registrations seek to monitor healthcare quality. The goal of the study is to measure between-hospital variation in risk-standardized survival outcome after glioblastoma surgery and to explore the association between survival and hospital characteristics in conjunction with patient-related risk factors.

METHODS:

Data of 2,409 adults with first-time glioblastoma surgery at 14 hospitals were obtained from a comprehensive, prospective population-based Quality Registry Neuro Surgery in The Netherlands between 2011 and 2014. We compared the observed survival with patient-specific risk-standardized expected early (30-day) mortality and late (2-year) survival, based on age, performance, and treatment year. We analyzed funnel plots, logistic regression and proportional hazards models.

RESULTS:

Overall 30-day mortality was 5.2% and overall 2-year survival was 13.5%. Median survival varied between 4.8 and 14.9 months among hospitals, and biopsy percentages ranged between 16 and 73%. One hospital had lower than expected early mortality, and four hospitals had lower than expected late survival. Higher case volume was related with lower early mortality (P = 0.031). Patient-related risk factors (lower age; better performance; more recent years of treatment) were significantly associated with longer overall survival. Of the hospital characteristics, longer overall survival was associated with lower biopsy percentage (HR 2.09, 1.34-3.26, P = 0.001), and not with academic setting, nor with case volume.

CONCLUSIONS:

Hospitals vary more in late survival than early mortality after glioblastoma surgery. Widely varying biopsy percentages indicate treatment variation. Patient-related factors have a stronger association with overall survival than hospital-related factors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Sistema de Registros / Avaliação de Resultados em Cuidados de Saúde / Mortalidade Hospitalar / Glioblastoma / Procedimentos Neurocirúrgicos / Hospitais Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Neurooncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Sistema de Registros / Avaliação de Resultados em Cuidados de Saúde / Mortalidade Hospitalar / Glioblastoma / Procedimentos Neurocirúrgicos / Hospitais Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Neurooncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda